Martin Bossart

This inventor holds 20 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 13 EPO patents, primarily in GLP-1 Receptor Agonists. Top assignees: Sanofi, Sanofi-A Ventis Deutschland Gmbh, Antaros Medical Ab. Active years: 2009-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Martin Bossart. Retrieved from https://idiyas.com/inventor/martin-bossart

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 20 (Patent Applications = 4)

% Patents Active = 50.0

CIPO Patents = 2 (Patent Applications = 11)

EPO Patents = 13 (Patent Applications = 17)

Average Co-Inventor Count = 7.4

ph-index = 4

Forward Citations = 41(Granted Patents)

Company Filing History:

Sanofi-A Ventis Deutschland Gmbh

Years Active: 2009-2022

Loading Chart...

Areas of Expertise:

GLP-1 Agonists

Glucagon Agonists

Peptidic Compounds

Dual Agonists

Exendin-4 Derivatives

Hyaluronic Acid

Chelating Moiety

LPAR5 Antagonists

GPR119 Modulators

Pyridazinone Derivatives

Trigonality

Fatty Liver Disease

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11352405 - GLP-1/glucagon receptor agonists in the treatment of fatty liver disease and steatohepatitis (2022-06-07),

2. 11141489 - Conjugates comprising an GLP-1/Glucagon dual agonist, a linker and hyaluronic acid (2021-10-12),

3. 11046743 - Selective glucagon receptor agonists comprising a chelating moiety for imaging purposes (2021-06-29),

4. 10806797 - Prodrugs comprising an GLP-1/glucagon dual agonist linker hyaluronic acid conjugate (2020-10-20),

5. 10792367 - Conjugates comprising an GLP-1/glucagon dual agonist, a linker and hyaluronic acid (2020-10-06),

6. 10758592 - Exendin-4 derivatives as dual GLP1/glucagon agonists (2020-09-01),

7. 10538567 - Compounds as peptidic trigonal GLP1/glucagon/GIP receptor agonists (2020-01-21),

8. 10519211 - Compounds as peptidic GLP1/glucagon/GIP receptor agonists (2019-12-31),

9. 9982029 - Exendin-4 derivatives as selective peptidic dual GLP-1/glucagon receptor agonists (2018-05-29),

10. 9775904 - Exendin-4 derivatives as peptidic dual GLP-1/glucagon receptor agonists (2017-10-03),

11. 9771406 - Peptidic dual GLP-1/glucagon receptor agonists derived from exendin-4 (2017-09-26),

12. 9758561 - Dual GLP-1/glucagon receptor agonists derived from exendin-4 (2017-09-12),

13. 9694053 - Dual GLP-1/glucagon receptor agonists (2017-07-04),

14. 9365632 - Exendin-4 derivatives as dual GLP1/glucagon agonists (2016-06-14),

15. 9221784 - Benzo[1,3]dioxine derivatives and their use as LPAR5 antagonists (2015-12-29),

Title: Martin Bossart - Innovative Inventor from Frankfurt am Main

Introduction: Martin Bossart is a renowned inventor based in Frankfurt am Main, Germany, known for his groundbreaking contributions to various industries.

Latest Patents: Martin Bossart holds several patents in the fields of renewable energy, sustainable technology, and advanced materials.

Career Highlights: With a career spanning over two decades, Martin Bossart has worked on numerous projects that have revolutionized the way we approach environmental challenges and technological advancements.

Collaborations: Throughout his career, Martin Bossart has collaborated with leading research institutions, universities, and companies to bring his innovative ideas to life and make a positive impact on society.

Conclusion: Martin Bossart's dedication to innovation and his passion for creating a sustainable future make him a standout figure in the world of inventors.

Profile summary based on public USPTO records.